Get the Stockscreener App
1.93
4.89%
0.09
Heron Therapeutics Inc stock is traded at $1.93, with a volume of 1.19M.
It is up +4.89% in the last 24 hours and down -18.91% over the past month.
Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.
See More
Previous Close:
$1.84
Open:
$1.82
24h Volume:
1.19M
Relative Volume:
0.73
Market Cap:
$294.00M
Revenue:
$137.74M
Net Income/Loss:
$-27.97M
P/E Ratio:
-12.06
EPS:
-0.16
Net Cash Flow:
$-9.61M
1W Performance:
+0.00%
1M Performance:
-18.91%
6M Performance:
+6.63%
1Y Performance:
-26.89%
1-Day Range:
$1.81
$1.99
1-Week Range:
$1.7909
$2.00
52-Week Range:
$1.04
$3.93
Heron Therapeutics Inc Stock (HRTX) Company Profile
Name
Heron Therapeutics Inc
Sector
Industry
Phone
(858) 251-4400
Address
4242 CAMPUS POINT COURT, SUITE 200, SAN DIEGO, CA
Compare HRTX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HRTX
Heron Therapeutics Inc
|
1.93 | 294.00M | 137.74M | -27.97M | -9.61M | -0.16 |
|
VRTX
Vertex Pharmaceuticals Inc
|
477.52 | 127.47B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.49 | 62.43B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
595.70 | 37.03B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
232.75 | 31.06B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
229.22 | 26.16B | 3.81B | -644.79M | -669.77M | -6.24 |
Heron Therapeutics Inc Stock (HRTX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-13-24 | Initiated | Rodman & Renshaw | Buy |
| Apr-23-24 | Initiated | CapitalOne | Overweight |
| Mar-13-24 | Reiterated | Needham | Buy |
| May-27-20 | Initiated | Guggenheim | Buy |
| Feb-20-20 | Reiterated | Needham | Buy |
| Jan-16-19 | Reiterated | Needham | Buy |
| Apr-05-18 | Initiated | Evercore ISI | Outperform |
| Mar-19-18 | Reiterated | Mizuho | Buy |
| Mar-01-18 | Reiterated | Needham | Buy |
| Jan-03-18 | Initiated | Leerink Partners | Outperform |
| Sep-27-17 | Initiated | Northland Capital | Outperform |
| Feb-27-17 | Initiated | Needham | Buy |
| Oct-26-16 | Initiated | Aegis Capital | Buy |
| Sep-06-16 | Resumed | Lake Street | Buy |
| May-03-16 | Initiated | Cantor Fitzgerald | Buy |
| Dec-10-15 | Initiated | Lake Street | Buy |
| Sep-23-15 | Reiterated | Leerink Partners | Outperform |
| Sep-02-15 | Initiated | BofA/Merrill | Buy |
| Aug-03-15 | Reiterated | Brean Capital | Buy |
| Jun-30-15 | Reiterated | JMP Securities | Mkt Outperform |
| Jun-19-15 | Reiterated | Leerink Partners | Outperform |
| Aug-07-14 | Initiated | Noble Financial | Buy |
View All
Heron Therapeutics Inc Stock (HRTX) Latest News
Lacklustre Performance Is Driving Heron Therapeutics, Inc.'s (NASDAQ:HRTX) 26% Price Drop - simplywall.st
Quinn Opportunity Partners LLC Acquires New Position in Heron Therapeutics, Inc. (NASDAQ:HRTX) - MarketBeat
Raymond James Financial Inc. Takes $208,000 Position in Heron Therapeutics, Inc. (NASDAQ:HRTX) - MarketBeat
Heron Therapeutics (NASDAQ:HRTX) Earns "Buy" Rating from Needham & Company LLC - MarketBeat
Wellington Management Group LLP Sells 8,105 Shares of Heron Therapeutics, Inc. (NASDAQ:HRTX) - Defense World
Heron Therapeutics’ (HRTX) Buy Rating Reiterated at Needham & Company LLC - Defense World
Raymond James Financial Inc. Takes Position in Heron Therapeutics, Inc. (NASDAQ:HRTX) - Defense World
Exploring High Growth Tech Stocks In The US Market April 2025 - Yahoo
Heron Therapeutics, Inc.'s (NASDAQ:HRTX) Path To Profitability - simplywall.st
Heron Therapeutics, Inc. (NASDAQ:HRTX) Position Increased by Charles Schwab Investment Management Inc. - Defense World
Loss-Making Heron Therapeutics, Inc. (NASDAQ:HRTX) Expected To Breakeven In The Medium-Term - Yahoo
Is Heron Therapeutics, Inc. (HRTX) The Hot Biotech Stock Under $5? - Insider Monkey
Reviewing Heron Therapeutics (NASDAQ:HRTX) and ULURU (OTCMKTS:ULUR) - Defense World
Richmond Brothers Inc. Raises Stake in Heron Therapeutics, Inc. (NASDAQ:HRTX) - MarketBeat
Tejara Capital Ltd Reduces Holdings in Heron Therapeutics, Inc. (NASDAQ:HRTX) - MarketBeat
10 Hot Biotech Stocks Under $5 - Insider Monkey
Monaco Asset Management SAM Sells 465,674 Shares of Heron Therapeutics, Inc. (NASDAQ:HRTX) - MarketBeat
Heron Therapeutics to Report Fourth Quarter and Full Year 2024 F - GuruFocus.com
Heron Therapeutics (HRTX) Projected to Post Quarterly Earnings on Tuesday - MarketBeat
StockNews.com Downgrades Heron Therapeutics (NASDAQ:HRTX) to Hold - MarketBeat
CM Management LLC Acquires 200,000 Shares of Heron Therapeutics, Inc. (NASDAQ:HRTX) - MarketBeat
Why Heron Therapeutics Inc Stock Might Make Sense If Bought Today - Stocks Register
Los Angeles Capital Management LLC Sells 153,181 Shares of Heron Therapeutics, Inc. (NASDAQ:HRTX) - MarketBeat
Principal Financial Group Inc. Raises Stock Position in Heron Therapeutics, Inc. (NASDAQ:HRTX) - Defense World
Heron Therapeutics (HRTX) to Release Quarterly Earnings on Tuesday - Defense World
Heron Therapeutics: Four Horse Race Of Approved Therapies (NASDAQ:HRTX) - Seeking Alpha
Heron Therapeutics (NASDAQ:HRTX) Downgraded by StockNews.com to Hold - Defense World
Heron Therapeutics (HRTX) to Release Earnings on Tuesday - MarketBeat
What is Northland Capmk's Estimate for HRTX Q1 Earnings? - MarketBeat
Heron Therapeutics, Inc. (NASDAQ:HRTX) Stock Position Decreased by Los Angeles Capital Management LLC - The AM Reporter
Heron Therapeutics (NASDAQ:HRTX) Raised to "Buy" at StockNews.com - MarketBeat
Heron Therapeutics (NASDAQ:HRTX) Posts Earnings Results, Beats Expectations By $0.05 EPS - MarketBeat
Heron Therapeutics, Inc. (NASDAQ:HRTX) Shares Sold by D.A. Davidson & CO. - MarketBeat
Heron Therapeutics Inc Stock (HRTX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.15%
4.32%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):